MétaCan
Menu
← Back to cohort
Record W4406209800 · doi:10.1002/alz.092467

Screening for preclinical and prodromal Alzheimer disease clinical trials: predicting NIA‐AA research framework ATN category by leveraging neuropsychiatric symptoms

2024· article· en· W4406209800 on OpenAlexaff
Zahinoor Ismail, Rebeca Leon, Dylan X. Guan, Eric E. Smith

Bibliographic record

VenueAlzheimer s & Dementia · 2024
Typearticle
Languageen
FieldMedicine
TopicDementia and Cognitive Impairment Research
Canadian institutionsHotchkiss Brain InstituteUniversity of Calgary
Fundersnot available
KeywordsClinical trialAlzheimer's diseaseDiseaseMedicinePsychologyPsychiatryInternal medicine

Abstract

fetched live from OpenAlex

Abstract Background As disease‐modifying therapies for Alzheimer disease (AD) emerge, the need for earlier detection becomes increasingly important. Biomarker confirmation is expensive and invasive, only implemented for persons at risk. Risk is usually assigned based on cognitive decline. Accordingly, detection at NIA‐AA Research Framework Stage 2 (preclinical disease) or early Stage 3 (prodromal) is suboptimal. Whether incorporating neuropsychiatric symptoms (NPS) helps with detection remains in equipoise. However, by leveraging risk associated with later‐life emergent and persistent behavioral changes, Mild Behavioral Impairment (MBI) has demonstrated associations with lower amyloid‐β (Aβ) and higher tau levels in blood and CSF. Whether MBI can categorically predict prevalent AD is unclear. Here, we examined cross‐sectional associations between MBI and cerebrospinal fluid (CSF) [AT(N)] biomarker categories. Method Dementia‐free participants (n=984) from the Alzheimer's Disease Neuroimaging Initiative were included. Using the validated two‐thirds visit method to operationalize symptom persistence, NPS (identified using the Neuropsychiatric Inventory or Neuropsychiatric Inventory Questionnaire) were categorized into three NPS groups: 1) NoNPS; 2) NPS not meeting MBI criteria (NPSnotMBI); and 3) MBI. Consistent with the [AT(N)] framework, three biomarker profiles were described: 1) normal AD biomarkers; 2) AD continuum (low CSF Aβ1‐42); and 3) non‐AD pathologic change (normal Aβ, elevated CSF p‐tau181 and/or t‐tau). Gaussian Mixture Modeling (GMM) was used to determine biomarker positivity thresholds with Winsorization of extreme values. Logistic regression modeled associations between MBI status and CSF biomarker positivity, adjusted for age, sex, education, and MMSE score. Multinomial logistic regression modeled associations between MBI status and [AT(N)] biomarker profile. Result Table 1 shows demographics. Compared to the NoNPS group, MBI was significantly associated with Aβ positivity (OR=2.35, 95%CI=1.70–3.26, p<0.001), p‐tau181 positivity (OR=2.15, 95%CI=1.56–2.96, p<0.001), and t‐tau positivity (OR=1.89, 95%CI=1.37–2.59, p<0.001), while NPSnotMBI was not (Table 2). Multinomial logistic regression indicated a significant association between MBI+ status and the AD continuum category (OR=2.56, 95%CI=1.77–3.69, p<0.001), but not non‐AD pathologic change (Table 3). Conclusion In dementia‐free older individuals, MBI predicts Aβ‐positivity and AD+ status over non‐AD pathological change; no associations were found with NPSnotMBI. Incorporating MBI into AD trial screening can improve disease detection and reduce screen failures.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.014
metaresearch head score (Gemma)0.018
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.014
Threshold uncertainty score0.072

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0140.018
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0020.001
Science and technology studies0.0010.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.243
GPT teacher head0.500
Teacher spread0.257 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & Dementia→Same topicDementia and Cognitive Impairment Research→French-language works237,207→